Miriam Deane

1.0k total citations
22 papers, 845 citations indexed

About

Miriam Deane is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Miriam Deane has authored 22 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Hematology and 8 papers in Immunology. Recurrent topics in Miriam Deane's work include Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Miriam Deane is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Miriam Deane collaborates with scholars based in United Kingdom, Ireland and France. Miriam Deane's co-authors include John D. Norton, Keith McCarthy, Leanne M. Wiedemann, H. G. Prentice, Bartrum W. Baker, Timothy Corbett, Graeme Smith, Neil A Murray, Patrick Chu and Peter Ganly and has published in prestigious journals such as Nucleic Acids Research, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

Miriam Deane

22 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Deane United Kingdom 14 357 316 272 246 236 22 845
MJ Brisco Australia 9 191 0.5× 229 0.7× 172 0.6× 342 1.4× 159 0.7× 9 706
AM Levine United States 15 290 0.8× 156 0.5× 204 0.8× 297 1.2× 146 0.6× 22 893
B Varet France 12 376 1.1× 222 0.7× 194 0.7× 260 1.1× 192 0.8× 46 874
Emilienne Kühlein France 16 278 0.8× 223 0.7× 267 1.0× 282 1.1× 258 1.1× 30 850
Jean-Philippe Laporte France 12 486 1.4× 296 0.9× 139 0.5× 492 2.0× 116 0.5× 13 1.0k
B A Reichard United States 8 287 0.8× 161 0.5× 292 1.1× 126 0.5× 273 1.2× 8 830
HJ Weinstein United States 11 341 1.0× 116 0.4× 247 0.9× 162 0.7× 183 0.8× 18 710
S N Rabinowe United States 11 467 1.3× 209 0.7× 263 1.0× 371 1.5× 109 0.5× 12 914
IL Wolvers-Tettero Netherlands 9 255 0.7× 137 0.4× 235 0.9× 148 0.6× 294 1.2× 13 622
RE Sobol United States 11 681 1.9× 296 0.9× 177 0.7× 171 0.7× 699 3.0× 15 1.1k

Countries citing papers authored by Miriam Deane

Since Specialization
Citations

This map shows the geographic impact of Miriam Deane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Deane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Deane more than expected).

Fields of papers citing papers by Miriam Deane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Deane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Deane. The network helps show where Miriam Deane may publish in the future.

Co-authorship network of co-authors of Miriam Deane

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Deane. A scholar is included among the top collaborators of Miriam Deane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Deane. Miriam Deane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deane, Miriam, Charles R.J. Singer, Mark Lawler, et al.. (1998). Acute skin GVHD following syngeneic BMT for CLL. Bone Marrow Transplantation. 22(12). 1207–1209. 6 indexed citations
3.
Deane, Miriam, Mickey Koh, Letizia Foroni, et al.. (1998). FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission. Bone Marrow Transplantation. 22(12). 1137–1143. 19 indexed citations
4.
Corbett, Timothy, et al.. (1997). The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplantation. 19(9). 891–897. 42 indexed citations
5.
Deane, Miriam, et al.. (1997). Quantification of CMV viraemia in a case of transfusion‐related graft‐versus‐host disease associated with purine analogue treatment. British Journal of Haematology. 99(1). 162–164. 6 indexed citations
6.
Baker, Bartrum W., et al.. (1994). Distinctive Features of Immunoglobulin Heavy Chain Variable Region Gene Rearrangement in Multiple Myeloma. Leukemia & lymphoma. 14(3-4). 291–301. 14 indexed citations
7.
Murray, Neil A, Dominique Acolet, Miriam Deane, J. L. Price, & Irene Roberts. (1994). Fetal marrow suppression after maternal chemotherapy for leukaemia.. Archives of Disease in Childhood Fetal & Neonatal. 71(3). F209–F210. 24 indexed citations
8.
Deane, Miriam, Bartrum W. Baker, & John D. Norton. (1993). Immunoglobulin VH4 gene usage in B lymphoid leukaemias. British Journal of Haematology. 84(2). 242–249. 20 indexed citations
9.
Deane, Miriam & A. Victor Hoffbrand. (1993). Detection of minimal residual disease in ALL. Cancer treatment and research. 64. 135–170. 10 indexed citations
10.
Deane, Miriam, Lorna Mackenzie, Freda K. Stevenson, et al.. (1993). The Genetic Basis of Human Vh4 Gene Family‐Associated Cross‐Reactive Idiotype Expression in CD5+ and CD5‐ Cord Blood B‐Lymphocyte Clones. Scandinavian Journal of Immunology. 38(4). 348–358. 15 indexed citations
11.
Lydyard, Peter M., Lorna Mackenzie, Pierre Youinou, et al.. (1992). Specificity and Idiotope Expression of IgM Produced by CD5+ and CD5− Cord Blood B‐Cell Clonesa. Annals of the New York Academy of Sciences. 651(1). 527–539. 6 indexed citations
12.
Deane, Miriam & John D. Norton. (1991). Detection of Immunoglobulin Gene Rearrangement in B Cell Neoplasias by Polymerase Chain Reaction Gene Amplification. Leukemia & lymphoma. 5(1). 9–22. 16 indexed citations
13.
Deane, Miriam & John D. Norton. (1991). Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematology. 77(3). 274–281. 108 indexed citations
14.
Deane, Miriam, et al.. (1991). Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukaemia.. PubMed. 5(10). 832–8. 40 indexed citations
15.
Deane, Miriam, et al.. (1991). Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias.. PubMed. 5(8). 646–50. 40 indexed citations
16.
Deane, Miriam & John D. Norton. (1990). Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. European Journal of Immunology. 20(10). 2209–2217. 133 indexed citations
17.
Deane, Miriam & John D. Norton. (1990). Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. British Journal of Haematology. 74(3). 251–256. 85 indexed citations
18.
Deane, Miriam & John D. Norton. (1990). Immunoglobulin heavy chain gene rearrangement involving V-V region recombination. Nucleic Acids Research. 18(6). 1652–1652. 10 indexed citations
19.
Amos, R., et al.. (1990). Observations on the haemopoietic response to critical illness.. Journal of Clinical Pathology. 43(10). 850–856. 13 indexed citations
20.
Dorey, E., et al.. (1989). Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL). British Journal of Cancer. 59(5). 772–774. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MJ Brisco Breakdown of academic impact, for papers by AM Levine Breakdown of academic impact, for papers by B Varet Breakdown of academic impact, for papers by Emilienne Kühlein Breakdown of academic impact, for papers by Jean-Philippe Laporte Breakdown of academic impact, for papers by B A Reichard Breakdown of academic impact, for papers by HJ Weinstein Breakdown of academic impact, for papers by S N Rabinowe Breakdown of academic impact, for papers by IL Wolvers-Tettero Breakdown of academic impact, for papers by RE Sobol
Rankless by CCL
2026